Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pulmonary Hypertension, March 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 217 articles:
HTML format


 

Single Articles

  1. SONG X, Yang K, Chen G, Duan W, et al
    Characteristics and risk factors of pulmonary hypertension in patients with hyperthyroidism.
    Endocr Pract. 2021 Feb 23. pii: S1530-891X(21)00055.
    PubMed    
    Abstract available

  2. DIEPENBRUCK S, Dalla-Pozza R, Pattathu J, Haas N, et al
    Successful intravascular pulmonary lithotripsy in a child with chronic thromboembolic pulmonary hypertension.
    Pediatr Pulmonol. 2021 Feb 25. doi: 10.1002/ppul.25338.
    PubMed    
    Abstract available

  3. SAKARIN S, Surachetpong SD, Rungsipipat A
    Corrigendum: The Expression of Proteins Related to Serotonin Pathway in Pulmonary Arteries of Dogs Affected With Pulmonary Hypertension Secondary to Degenerative Mitral Valve Disease.
    Front Vet Sci. 2021;8:655751.
    PubMed    
    Abstract available

  4. DAI Y, Yu B, Ai D, Yuan L, et al
    Mitochondrial Fission-Mediated Lung Development in Newborn Rats With Hyperoxia-Induced Bronchopulmonary Dysplasia With Pulmonary Hypertension.
    Front Pediatr. 2021;8:619853.
    PubMed    
    Abstract available

  5. DU Y, Yuan L, Zhou JG, Huang XY, et al
    Echocardiography evaluation of bronchopulmonary dysplasia-associated pulmonary hypertension: a retrospective observational cohort study.
    Transl Pediatr. 2021;10:73-82.
    PubMed    
    Abstract available

  6. VON VISGER TT, Lee D, Lyons A, Chang YP, et al
    Integrated Review of Psychosocial and Behavioral Health Assessments and Interventions in Pulmonary Hypertension.
    Nurs Res. 2021;70:150-161.
    PubMed    
    Abstract available

  7. TSUBONO M, Shimizu K, Sato S, Ito T, et al
    Chronic Thromboembolic Pulmonary Hypertension Due to Popliteal Vein Aneurysm.
    Int Med Case Rep J. 2021;14:101-106.
    PubMed    
    Abstract available

  8. NAWAYTOU H, Fineman JR, Moledina S, Ivy D, et al
    Practice patterns of pulmonary hypertension secondary to left heart disease among pediatric pulmonary hypertension providers.
    Pulm Circ. 2021;11:2045894021991446.
    PubMed    
    Abstract available

  9. ZHANG L, Yan P, Yang K, Wu S, et al
    Association between splenectomy and chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis.
    BMJ Open. 2021;11:e038385.
    PubMed    
    Abstract available

  10. RAJDEV K, Lahan S, Wichman T
    Role of pulmonary arterial capacitance in predicting mortality in patients with pulmonary hypertension: A systematic review and meta-analysis.
    Int J Cardiol. 2021 Feb 20. pii: S0167-5273(21)00296.
    PubMed    
    Abstract available

  11. TAVARES-SILVA M, Saraiva F, Pinto R, Amorim S, et al
    Comparison of levosimendan, NO, and inhaled iloprost for pulmonary hypertension reversibility assessment in heart transplant candidates.
    ESC Heart Fail. 2021 Feb 23. doi: 10.1002/ehf2.13168.
    PubMed    
    Abstract available

  12. MARSICO A, Dal Corso S, Farah de Carvalho E, Arakelian V, et al
    A more effective alternative to the 6-minute walk test for the assessment of functional capacity in patients with pulmonary hypertension.
    Eur J Phys Rehabil Med. 2021 Feb 23. pii: S1973-9087.21.06561.
    PubMed    
    Abstract available

  13. JORDAN L, Rodgers N, Roberts KD
    Transverse sinus dural arteriovenous fistula: a reversible cause of severe pulmonary hypertension in an extremely premature infant.
    BMJ Case Rep. 2021;14.
    PubMed    


  14. JASINSKA-STROSCHEIN M, Orszulak-Michalak D
    Reporting experimental studies on animals - The problems with translating of outcomes to clinical benefits. Methodological and statistical considerations: The example of pulmonary hypertension.
    Eur J Pharmacol. 2021;897:173952.
    PubMed    
    Abstract available

  15. SADAT B, Tirunagari D, Karthikeyan V, Patel A, et al
    Clinical impact of pre-kidney transplant pulmonary hypertension on post-transplant outcomes.
    Int J Cardiovasc Imaging. 2021 Feb 22. pii: 10.1007/s10554-021-02182.
    PubMed    
    Abstract available

  16. JOANNA R G V, Lopriore E, Te Pas AB, Rijken M, et al
    Persistent pulmonary hypertension in neonates with perinatal asphyxia and therapeutic hypothermia: a frequent and perilous combination.
    J Matern Fetal Neonatal Med. 2021 Feb 21:1-7. doi: 10.1080/14767058.2021.1873941
    PubMed    
    Abstract available

  17. SCHNEIDER M, Konig A, Geller W, Dannenberg V, et al
    Severe tricuspid regurgitation: prognostic role of right heart remodelling and pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2021 Feb 22. pii: 6146033.
    PubMed    
    Abstract available

  18. JIN X, Xu Y, Guo M, Sun Y, et al
    hsa_circNFXL1_009 modulates apoptosis, proliferation, migration, and potassium channel activation in pulmonary hypertension.
    Mol Ther Nucleic Acids. 2020;23:1007-1019.
    PubMed    
    Abstract available

  19. DURONGPISITKUL K, Chungsomprasong P, Vijarnsorn C, Chanthong P, et al
    Improved low-risk criteria scores for combination therapy of sildenafil and generic bosentan in patients with congenital heart disease with severe pulmonary hypertension: A prospective open label study.
    JRSM Cardiovasc Dis. 2021;10:2048004020982213.
    PubMed    
    Abstract available

  20. TAKASE T, Taniguchi M, Hirano Y, Nakazawa G, et al
    Sex difference in pulmonary hypertension in the evaluation by exercise echocardiography.
    Pulm Circ. 2021;11:2045894020988453.
    PubMed    
    Abstract available

  21. LIU G, Fu D, Tian H, Dai A, et al
    The mechanism of ions in pulmonary hypertension.
    Pulm Circ. 2021;11:2045894020987948.
    PubMed    
    Abstract available

  22. SULLIVAN RT, Tillman KA, Kindel SJ, Handler SS, et al
    Diazoxide-associated pulmonary hypertension in a patient with noncompaction cardiomyopathy.
    Pulm Circ. 2021;11:2045894020987117.
    PubMed    
    Abstract available

  23. LAI W, Ding Y, Wen L
    Long-term outcomes of pregnant women with pulmonary hypertension diagnosed by echocardiography: a retrospective cohort study in a single center from China.
    Pulm Circ. 2021;11:2045894020966876.
    PubMed    
    Abstract available

  24. CHO S, Namgoong H, Kim HJ, Vorn R, et al
    Downregulation of Soluble Guanylate Cyclase and Protein Kinase G With Upregulated ROCK2 in the Pulmonary Artery Leads to Thromboxane A2 Sensitization in Monocrotaline-Induced Pulmonary Hypertensive Rats.
    Front Physiol. 2021;12:624967.
    PubMed    
    Abstract available

  25. PRICE LC, Martinez G, Brame A, Pickworth T, et al
    Perioperative management of patients with pulmonary hypertension undergoing non-cardiothoracic, non-obstetric surgery: a systematic review and expert consensus statement.
    Br J Anaesth. 2021 Feb 18. pii: S0007-0912(21)00014.
    PubMed    
    Abstract available

  26. PANKL S, Baez M, Young P, Bruetman JE, et al
    [Whipple's disease and reversible pulmonary hypertension].
    Medicina (B Aires). 2021;81:91-95.
    PubMed    
    Abstract available

  27. ALI L, Ghazzal A, Radwan S, Barnett C, et al
    In-depth analysis of a case of persistent severe chronic thromboembolic pulmonary hypertension.
    Cardiovasc Revasc Med. 2020 Jul 10. pii: S1553-8389(20)30437.
    PubMed    
    Abstract available

  28. SUN X, Zhao B, Qu H, Chen S, et al
    Sera and lungs metabonomics reveals key metabolites of resveratrol protecting against PAH in rats.
    Biomed Pharmacother. 2021;133:110910.
    PubMed    
    Abstract available

  29. TANG C, Luo Y, Li S, Huang B, et al
    Characteristics of inflammation process in monocrotaline-induced pulmonary arterial hypertension in rats.
    Biomed Pharmacother. 2021;133:111081.
    PubMed    
    Abstract available

  30. YANG Y, Yin L, Zhu M, Song S, et al
    Protective effects of dioscin on vascular remodeling in pulmonary arterial hypertension via adjusting GRB2/ERK/PI3K-AKT signal.
    Biomed Pharmacother. 2021;133:111056.
    PubMed    
    Abstract available

  31. WALSH BK
    Inhaled Pulmonary Vasodilators in the Neonatal and Pediatric ICU.
    Respir Care. 2020;65:1611-1623.
    PubMed    
    Abstract available

  32. SUGIYAMA A, Kaisho M, Okada M, Otani K, et al
    Decreased Expression of Canstatin in Rat Model of Monocrotaline-Induced Pulmonary Arterial Hypertension: Protective Effect of Canstatin on Right Ventricular Remodeling.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  33. BASARICI I, Ozen N, Kilavuz E, Kisak F, et al
    Concealed role of red blood cells in pathogenesis of pulmonary arterial hypertension: Decreased red blood cell nitric oxide generation and effect of Rho-Kinase inhibitor fasudil.
    Clin Hemorheol Microcirc. 2020;76:535-548.
    PubMed    
    Abstract available

  34. VAN NUFFEL S, Quatredeniers M, Pirkl A, Zakel J, et al
    Multimodal Imaging Mass Spectrometry to Identify Markers of Pulmonary Arterial Hypertension in Human Lung Tissue Using MALDI-ToF, ToF-SIMS, and Hybrid SIMS.
    Anal Chem. 2020;92:12079-12087.
    PubMed    
    Abstract available

  35. CHANG CJ, Huang CC, Chen PR, Lai YJ, et al
    Remodeling Matrix Synthesis in a Rat Model of Aortocaval Fistula and the Cyclic Stretch: Impaction in Pulmonary Arterial Hypertension-Congenital Heart Disease.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  36. YANG Y, Lin F, Xiao Z, Sun B, et al
    Investigational pharmacotherapy and immunotherapy of pulmonary arterial hypertension: An update.
    Biomed Pharmacother. 2020;129:110355.
    PubMed    
    Abstract available

  37. KUCH BA, Linssen R, Yoshikawa H, Smallwood CD, et al
    Local Effects of Two Intravenous Formulations of Pulmonary Vasodilators on Airway Epithelium.
    Respir Care. 2020;65:1427-1432.
    PubMed    
    Abstract available

  38. ZHANG T, Kawaguchi N, Tsuji K, Hayama E, et al
    Silibinin Upregulates CXCR4 Expression in Cultured Bone Marrow Cells (BMCs) Especially in Pulmonary Arterial Hypertension Rat Model.
    Cells. 2020;9.
    PubMed    
    Abstract available

  39. YOO J, Ko J, Yoon H, Eom K, et al
    Caudal vena cava aneurysm in a cat with Eisenmenger Syndrome.
    J Vet Med Sci. 2020;82:784-787.
    PubMed    
    Abstract available

  40. KITANO A, Nakaguro M, Tomotaki S, Hanaoka S, et al
    A familial case of alveolar capillary dysplasia with misalignment of the pulmonary veins: the clinicopathological features and unusual glomeruloid endothelial proliferation.
    Diagn Pathol. 2020;15:48.
    PubMed    
    Abstract available

  41. XIAO G, Wang T, Zhuang W, Ye C, et al
    RNA sequencing analysis of monocrotaline-induced PAH reveals dysregulated chemokine and neuroactive ligand receptor pathways.
    Aging (Albany NY). 2020;12:4953-4969.
    PubMed    
    Abstract available

  42. STRASSHEIM D, Karoor V, Nijmeh H, Weston P, et al
    c-Jun, Foxo3a, and c-Myc Transcription Factors are Key Regulators of ATP-Mediated Angiogenic Responses in Pulmonary Artery Vasa Vasorum Endothelial Cells.
    Cells. 2020;9.
    PubMed    
    Abstract available

  43. ZHANG J, Li Y, Qi J, Yu X, et al
    Circ-calm4 Serves as an miR-337-3p Sponge to Regulate Myo10 (Myosin 10) and Promote Pulmonary Artery Smooth Muscle Proliferation.
    Hypertension. 2020;75:668-679.
    PubMed    
    Abstract available

  44. SANDNER P, Zimmer DP, Milne GT, Follmann M, et al
    Soluble Guanylate Cyclase Stimulators and Activators.
    Handb Exp Pharmacol. 2021;264:355-394.
    PubMed    
    Abstract available

  45. CHATURVEDI A, Baran TM, Ambrosini R, Krishnamoorthy V, et al
    Improving CT assessment for pulmonary hypertension in patients with severe aortic stenosis, correlation with right heart catheterization.
    Clin Imaging. 2021;77:122-129.
    PubMed    
    Abstract available

  46. SETLUR K, Priyadarshi M, Singh S, Verma A, et al
    A Masquerader of neonatal persistent pulmonary hypertension.
    J Pediatr. 2021 Mar 3. pii: S0022-3476(21)00207.
    PubMed    


  47. MARTINEZ MENACA A, Blanco Vich I, Lopez Meseguer M, Lopez Reyes R, et al
    From Health-Related Quality of Life (HRQoL) of Patients with Pulmonary Hypertension to Patient Experience with the Care Received: Should We Be More Aware of Current Patient Needs?
    Adv Ther. 2021 Mar 6. pii: 10.1007/s12325-021-01625.
    PubMed    
    Abstract available

  48. FURIAN M, Latshang TD, Aeschbacher SS, Sheraliev U, et al
    Markers of cardiovascular risk and their reversibility with acute oxygen therapy in Kyrgyz highlanders with high altitude pulmonary hypertension.
    Pulmonology. 2021 Mar 2. pii: S2531-0437(21)00049.
    PubMed    
    Abstract available

  49. LI K, Li Y, Yu Y, Ding J, et al
    Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension.
    BMC Pulm Med. 2021;21:80.
    PubMed    
    Abstract available

  50. OLSCHEWSKI H
    The Challenge to Decide between Pulmonary Hypertension Due to Chronic Lung Disease and PAH with Chronic Lung Disease.
    Diagnostics (Basel). 2021;11.
    PubMed    
    Abstract available

  51. LAKSHMINRUSIMHA S
    Neonatal and Postneonatal Pulmonary Hypertension.
    Children (Basel). 2021;8.
    PubMed    
    Abstract available

  52. NYHAN SM, Kolb TM, Steppan J
    Anesthetic techniques for patients with pulmonary hypertension undergoing ophthalmologic procedures: A case series.
    J Clin Anesth. 2021;71:110220.
    PubMed    


  53. CHINAWA JM, Chukwu BF, Chinawa AT, Duru CO, et al
    The effects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): a multi-center study.
    BMC Pulm Med. 2021;21:79.
    PubMed    
    Abstract available

  54. ZOU S, Cen Z, Jia R, Lu S, et al
    Electrophysiological study and radiofrequency ablation of hemodynamically-instable ventricular arrhythmias in a patient with pulmonary hypertension: A case report.
    Medicine (Baltimore). 2021;100:e24896.
    PubMed    
    Abstract available

  55. CONSTANTINE A, Condliffe R, Clift P, Tulloh R, et al
    Palliative care in pulmonary hypertension associated with congenital heart disease: systematic review and expert opinion.
    ESC Heart Fail. 2021 Mar 3. doi: 10.1002/ehf2.13263.
    PubMed    
    Abstract available

  56. SCHWARTZMANN P
    Sildenafil as an Eligible Heart Transplantation Therapy for Advanced Heart Failure Associated with Fixed Pulmonary Hypertension.
    Arq Bras Cardiol. 2021;116:227-228.
    PubMed    


  57. ZENG M, Chen S, Li H, Huang Z, et al
    The role of beta-catenin in pulmonary artery endothelial-mesenchymal transformation in rats with chronic thromboembolic pulmonary hypertension.
    J Thromb Thrombolysis. 2021 Mar 2. pii: 10.1007/s11239-020-02356.
    PubMed    
    Abstract available

  58. VANHIE E, VandeKerckhove K, Haas NA, De Wolf D, et al
    Atrial flow regulator for drug-resistant pulmonary hypertension in a young child.
    Catheter Cardiovasc Interv. 2021 Mar 2. doi: 10.1002/ccd.29590.
    PubMed    
    Abstract available

  59. DASGUPTA S, Bettermann E, Kelleman M, Kanaan U, et al
    N-terminal pro-B-type-natriuretic peptide as a screening tool for pulmonary hypertension in the paediatric population.
    Cardiol Young. 2021 Mar 2:1-13. doi: 10.1017/S1047951121000585.
    PubMed    
    Abstract available

  60. CHOI BH, Verma S, Cicalese E, Dapul H, et al
    Morbidity of conversion from venovenous to venoarterial ECMO in neonates with meconium aspiration or persistent pulmonary hypertension.
    J Pediatr Surg. 2021;56:459-464.
    PubMed    
    Abstract available

  61. MCGREGOR PC, Boosalis V, Aragam J
    Carfilzomib-induced pulmonary hypertension with associated right ventricular dysfunction: A case report.
    SAGE Open Med Case Rep. 2021;9:2050313X21994031.
    PubMed    
    Abstract available

  62. KIM D, Roberts C, McKenzie A, George MP, et al
    Nutritional ketosis to treat pulmonary hypertension associated with obesity and metabolic syndrome: a case report.
    Pulm Circ. 2021;11:2045894021991426.
    PubMed    
    Abstract available

  63. FARAJI MA, Hassanpour H, Bahadoran S, Kaewduangta W, et al
    Effect of Shirazi thyme on oxidant status and absorptive surface area of the intestine in cold-induced pulmonary hypertensive broiler chickens.
    Vet Res Forum. 2020;11:371-376.
    PubMed    
    Abstract available

  64. SHAFIQ M, Jagavelu K, Iqbal H, Yadav P, et al
    Inhibition of Mitogen-Activated Protein Kinase (MAPK)-Activated Protein Kinase 2 (MK2) is Protective in Pulmonary Hypertension.
    Hypertension. 2021 Mar 1:HYPERTENSIONAHA12015229.
    PubMed    
    Abstract available

  65. RAEVENS S, Geerts A, Devisscher L, Van Vlierberghe H, et al
    Recent advances in the approach to hepatopulmonary syndrome and portopulmonary hypertension.
    Acta Gastroenterol Belg. 2021;84:95-99.
    PubMed    
    Abstract available

  66. SINGH MK, Mobeen A, Chandra A, Joshi S, et al
    A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
    Comput Biol Med. 2021;130:104219.
    PubMed    
    Abstract available

  67. SUZUKI YJ, Nikolaienko SI, Shults NV, Gychka SG, et al
    COVID-19 patients may become predisposed to pulmonary arterial hypertension.
    Med Hypotheses. 2021;147:110483.
    PubMed    
    Abstract available

  68. SAHIN A, Kaya H, Avci O
    Cancer antigen-125 is a predictor of mortality in patients with pulmonary arterial hypertension.
    Clin Biochem. 2021;89:58-62.
    PubMed    
    Abstract available

  69. HIRSCHHAUSER C, Sydykov A, Wolf A, Esfandiary A, et al
    Lack of Contribution of p66shc to Pressure Overload-Induced Right Heart Hypertrophy.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  70. KOCKEN JMM, da Costa Martins PA
    Epigenetic Regulation of Pulmonary Arterial Hypertension-Induced Vascular and Right Ventricular Remodeling: New Opportunities?
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  71. ZOLA CE, Duncan MS, So-Armah K, Crothers KA, et al
    HIV- and HCV-specific markers and echocardiographic pulmonary artery systolic pressure among United States veterans.
    Sci Rep. 2020;10:18729.
    PubMed    
    Abstract available

  72. QIMIN W, LiangWan C, DaoZhong C, HanFan Q, et al
    Clinical outcomes of acute pulmonary embolectomy as the first-line treatment for massive and submassive pulmonary embolism: a single-centre study in China.
    J Cardiothorac Surg. 2020;15:321.
    PubMed    
    Abstract available

  73. HAPPE C, Kurakula K, Sun XQ, da Silva Goncalves Bos D, et al
    The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Cells. 2020;9.
    PubMed    
    Abstract available

  74. YILMAZ BC, Guclu MB, Keles MN, Tacoy GA, et al
    Effects of upper extremity aerobic exercise training on oxygen consumption, exercise capacity, dyspnea and quality of life in patients with pulmonary arterial hypertension.
    Heart Lung. 2020;49:564-571.
    PubMed    
    Abstract available

  75. ROSA GM, D'Agostino A, Giovinazzo S, La Malfa G, et al
    Echocardiography of right ventricular-arterial coupling predicts survival of elderly patients with heart failure and reduced to mid-range ejection fraction.
    Monaldi Arch Chest Dis. 2020;90.
    PubMed    
    Abstract available

  76. OU M, Li X, Cui S, Zhao S, et al
    Emerging roles of let7d in attenuating pulmonary arterial hypertension via suppression of pulmonary artery endothelial cell autophagy and endothelin synthesis through ATG16L1 downregulation.
    Int J Mol Med. 2020;46:83-96.
    PubMed    
    Abstract available

  77. WEDGWOOD S, Gerard K, Halloran K, Hanhauser A, et al
    Intestinal Dysbiosis and the Developing Lung: The Role of Toll-Like Receptor 4 in the Gut-Lung Axis.
    Front Immunol. 2020;11:357.
    PubMed    
    Abstract available

  78. DELL'AMORE A, Campisi A, Congiu S, Mazzarra S, et al
    Extracorporeal life support during and after bilateral sequential lung transplantation in patients with pulmonary artery hypertension.
    Artif Organs. 2019 Dec 30. doi: 10.1111/aor.13628.
    PubMed    
    Abstract available

  79. HOLLINGER LE, Buchmiller TL
    Long term follow-up in congenital diaphragmatic hernia.
    Semin Perinatol. 2020;44:151171.
    PubMed    
    Abstract available

  80. CORDIER AG, Russo FM, Deprest J, Benachi A, et al
    Prenatal diagnosis, imaging, and prognosis in Congenital Diaphragmatic Hernia.
    Semin Perinatol. 2020;44:51163.
    PubMed    
    Abstract available

  81. WAGNER R, Montalva L, Zani A, Keijzer R, et al
    Basic and translational science advances in congenital diaphragmatic hernia.
    Semin Perinatol. 2020;44:151170.
    PubMed    
    Abstract available

  82. PATEL N, Massolo AC, Kipfmueller F
    Congenital diaphragmatic hernia-associated cardiac dysfunction.
    Semin Perinatol. 2020;44:151168.
    PubMed    
    Abstract available

  83. ZHONG X, Tang J, Jiang R, Yuan P, et al
    The predictive value of minute ventilation versus carbon dioxide production in pulmonary hypertension associated with left heart disease.
    Ann Transl Med. 2021;9:351.
    PubMed    
    Abstract available


  84. Erratum to left ventricular ischemia in pre-capillary pulmonary hypertension: a cardiovascular magnetic resonance study.
    Cardiovasc Diagn Ther. 2021;11:341.
    PubMed    
    Abstract available

  85. BORDONES-CROM A, Patnaik S, Menon P, Murali S, et al
    Morphological Analysis of the Right Ventricular Endocardial Wall in Pulmonary Hypertension.
    J Biomech Eng. 2021 Mar 11. pii: 1103436. doi: 10.1115/1.4050457.
    PubMed    
    Abstract available

  86. MIOTTI C, D'Armini AM, Scardovi B, Ghio S, et al
    Chronic thromboembolic pulmonary hypertension risk score evaluation and validation (CTEPH Solution): proposal of a study protocol aimed to realize a validated risk score for early diagnosis.
    Minerva Cardiol Angiol. 2021 Mar 11. pii: S2724-5683.21.05575.
    PubMed    
    Abstract available

  87. JAIN PP, Zhao T, Xiong M, Song S, et al
    Halofuginone, a Promising Drug for Treatment of Pulmonary Hypertension.
    Br J Pharmacol. 2021 Mar 10. doi: 10.1111/bph.15442.
    PubMed    
    Abstract available

  88. TAMURA Y, Takeyasu R, Furukawa A, Takada H, et al
    How COVID-19 Affected the Introduction of Telemedicine and Patient Reported Outcomes Among Patients With Pulmonary Hypertension- A Report From a Referral Center in Japan.
    Circ Rep. 2020;2:526-530.
    PubMed    
    Abstract available

  89. KUBOTA K, Miyanaga S, Iwatani N, Higo K, et al
    Geriatric Nutritional Risk Index Is Associated With Prognosis in Patients With Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension.
    Circ Rep. 2020;2:372-377.
    PubMed    
    Abstract available

  90. TAKEYASU R, Tamura Y, Abe K, Goda A, et al
    Psychometric Validation of a Japanese Version of the emPHasis-10 Questionnaire, a Patient-Reported Outcome Measure for Pulmonary Hypertension- Multicenter Study in Japan.
    Circ Rep. 2020;2:255-259.
    PubMed    
    Abstract available

  91. ISHIGURO M, Takeuchi K, Kikuchi H, Goda A, et al
    Pulmonary Artery Pressure as a Treatment Target to Improve the Prognosis of Idiopathic Pulmonary Arterial Hypertension- Insight From a Cohort From Two Japanese Pulmonary Hypertension Centers.
    Circ Rep. 2020;2:249-254.
    PubMed    
    Abstract available

  92. NISHINA Y, Inami T, Kataoka M, Kariyasu T, et al
    Evaluation of Right Ventricular Function on Cardiac Magnetic Resonance Imaging and Correlation With Hemodynamics in Patients With Chronic Thromboembolic Pulmonary Hypertension.
    Circ Rep. 2020;2:174-181.
    PubMed    
    Abstract available

  93. SUMIMOTO K, Tanaka H, Mukai J, Yamashita K, et al
    Optimal Cut-Off of Tricuspid Regurgitation Velocity According to the New Definition of Pulmonary Hypertension- Its Use in Predicting Pulmonary Hypertension.
    Circ Rep. 2020;2:625-629.
    PubMed    
    Abstract available

  94. NUKALA SB, Tura-Ceide O, Aldini G, Smolders VFED, et al
    Protein network analyses of pulmonary endothelial cells in chronic thromboembolic pulmonary hypertension.
    Sci Rep. 2021;11:5583.
    PubMed    
    Abstract available

  95. HIRAISHI K, Kurahara LH, Feng J, Yamamura A, et al
    Substantial involvement of TRPM7 inhibition in the therapeutic effect of Ophiocordyceps sinensis on pulmonary hypertension.
    Transl Res. 2021 Mar 7. pii: S1931-5244(21)00054.
    PubMed    
    Abstract available

  96. KIPFMUELLER F
    Response to: EHD-D-21-00009 - N-terminal pro-B-type natriuretic peptide, pulmonary hypertension and cardiac dysfunction in patients with congenital diaphragmatic hernia.
    Early Hum Dev. 2021;155:105333.
    PubMed    


  97. EYHARTS D, Pascal P, Lavie-Badie Y, Cariou E, et al
    Impact of pulmonary perfusion defects by scintigraphy on pulmonary vascular resistances, functional capacity and right ventricular systolic function in patients with chronic thromboembolic pulmonary hypertension.
    Am J Nucl Med Mol Imaging. 2021;11:20-26.
    PubMed    
    Abstract available

  98. SLAWEK-SZMYT S, Araszkiewicz A, Trojnarska O, Markiewicz A, et al
    Closure of secundum atrial septal defect with a fenestrated occluder in a patient with severe pulmonary hypertension.
    Kardiol Pol. 2021 Mar 3. doi: 10.33963/KP.15855.
    PubMed    


  99. KOVACS Z, Guth S, Fistera D, Taube C, et al
    [Congenital Pulmonary Artery Stenoses as a Rare Cause of Pulmonary Hypertension].
    Pneumologie. 2021 Mar 8. doi: 10.1055/a-1362-4996.
    PubMed    
    Abstract available

  100. MATSUOKA Y, Taniguchi Y, Miwa K, Sumimoto K, et al
    Assessment of oxygenation after balloon pulmonary angioplasty for patients with inoperable chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2021 Mar 5. pii: S0167-5273(21)00459.
    PubMed    
    Abstract available

  101. TZOUVELEKIS A, Voulgaris A, Steiropoulos P
    Obstructive sleep apnea in patients with idiopathic pulmonary fibrosis: pulmonary hypertension could be the missing link for the diagnosis and different positive airway pressure treatment outcomes.
    J Clin Sleep Med. 2021 Mar 8. doi: 10.5664/jcsm.9204.
    PubMed    


  102. HASEGAWA M, Iwai S, Ishimaru K
    Surgical treatment of isolated unilateral absence of pulmonary artery with pulmonary hypertension.
    Cardiol Young. 2021 Mar 8:1-2. doi: 10.1017/S104795112100069.
    PubMed    
    Abstract available

  103. PANA TA, Dawson DK, Mohamed MO, Murray F, et al
    Sex Differences in Ischemic Stroke Outcomes in Patients With Pulmonary Hypertension.
    J Am Heart Assoc. 2021 Mar 8:e019341. doi: 10.1161/JAHA.120.019341.
    PubMed    
    Abstract available

  104. CHEN IC, Lin JY, Liu YC, Chai CY, et al
    Angiotensin-Converting Enzyme 2 Activator Ameliorates Severe Pulmonary Hypertension in a Rat Model of Left Pneumonectomy Combined With VEGF Inhibition.
    Front Med (Lausanne). 2021;8:619133.
    PubMed    
    Abstract available

  105. KABIYEVA S, Jalali S, Mindubayeva F, Igimbayeva G, et al
    Severe pulmonary hypertension associated with common arterial trunk in a 9- year- old child.
    Caspian J Intern Med. 2020;11:454-457.
    PubMed    
    Abstract available

  106. SIDDIQUE M, Nawaz MK, Khalid MB, Rai A, et al
    Right to Left Intrapulmonary Shunt in a Case with COVID-19-associated Pneumonia.
    J Coll Physicians Surg Pak. 2021;30:S23-S25.
    PubMed    
    Abstract available

  107. FRATICELLI S, Bonometti A, Lucioni M, Capuano F, et al
    Late-onset EBV-related post-transplant non-secreting plasma-cell neoplasms: Description of two cases.
    Leuk Res. 2021;100:106493.
    PubMed    


  108. GERTHOFFER W
    Epigenetic Targets for Oligonucleotide Therapies of Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  109. HOLDA MK, Stachowicz A, Suski M, Wojtysiak D, et al
    Myocardial proteomic profile in pulmonary arterial hypertension.
    Sci Rep. 2020;10:14351.
    PubMed    
    Abstract available

  110. CAI Z, Tu L, Guignabert C, Merkus D, et al
    Purinergic Dysfunction in Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2020;9:e017404.
    PubMed    
    Abstract available

  111. JURNEY PL, Glynn JJ, Dykan IV, Hagen MW, et al
    Characterization of a pulsatile rotary total artificial heart.
    Artif Organs. 2021;45:135-142.
    PubMed    
    Abstract available

  112. MENG L, Teng X, Liu Y, Yang C, et al
    Vital Roles of Gremlin-1 in Pulmonary Arterial Hypertension Induced by Systemic-to-Pulmonary Shunts.
    J Am Heart Assoc. 2020;9:e016586.
    PubMed    
    Abstract available

  113. ESCRIBANO-SUBIAS P, Lopez R, Almenar L, Lazaro M, et al
    Changes in REVEAL risk score in patients with pulmonary arterial hypertension treated with macitentan in clinical practice: results from the PRACMA study.
    BMC Pulm Med. 2020;20:154.
    PubMed    
    Abstract available

  114. HSU S, Simpson CE, Houston BA, Wand A, et al
    Multi-Beat Right Ventricular-Arterial Coupling Predicts Clinical Worsening in Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2020;9:e016031.
    PubMed    
    Abstract available

  115. IMAMURA T, Narang N, Kim G, Raikhelkar J, et al
    Decoupling Between Diastolic Pulmonary Artery and Pulmonary Capillary Wedge Pressures Is Associated With Right Ventricular Dysfunction and Hemocompatibility-Related Adverse Events in Patients With Left Ventricular Assist Devices.
    J Am Heart Assoc. 2020;9:e014801.
    PubMed    
    Abstract available

  116. ZHAO H, Guo Y, Sun Y, Zhang N, et al
    miR-181a/b-5p ameliorates inflammatory response in monocrotaline-induced pulmonary arterial hypertension by targeting endocan.
    J Cell Physiol. 2020;235:4422-4433.
    PubMed    
    Abstract available

  117. REN W, Guo JJ, Yang F, Yang ZW, et al
    Indication of the prognosis of pulmonary hypertension by using CMR function parameters.
    Eur Radiol. 2021 Mar 18. pii: 10.1007/s00330-021-07835.
    PubMed    
    Abstract available

  118. ADACHI S, Kikuchi R, Shimokata S, Suzuki A, et al
    Endostatin and Vascular Endothelial Growth Factor-A165b May Contribute to Classification of Pulmonary Hypertension.
    Circ Rep. 2021;3:161-169.
    PubMed    
    Abstract available

  119. ZWICKE DL, Restrepo-Jaramillo R, Alnuaimat H, Gordon K, et al
    A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinil.
    Pulm Circ. 2021;11:2045894021998203.
    PubMed    
    Abstract available

  120. L C, S C, C D, M A, et al
    Pulmonary arterial hypertension-associated genetic variants in combined post-capillary and pre-capillary pulmonary hypertension: a case report.
    Pulm Circ. 2021;11:2045894021996571.
    PubMed    
    Abstract available

  121. JACKSON EO, Brown A, McSweeney J, Parker C, et al
    Pediatric subcutaneous treprostinil site maintenance and pain control strategies from the Pediatric Pulmonary Hypertension Network.
    Pulm Circ. 2021;11:2045894021994450.
    PubMed    
    Abstract available

  122. ABDELBASER I, Mageed NA, Elfayoumy SI, Elgamal MF, et al
    The direct comparison of inhaled versus intravenous levosimendan in children with pulmonary hypertension undergoing on-cardiopulmonary bypass cardiac surgery: A randomized, controlled, non-inferiority study.
    J Clin Anesth. 2021;71:110231.
    PubMed    
    Abstract available

  123. RADCHENKO GD, Sirenko YM
    Prognostic Significance of Systemic Arterial Stiffness Evaluated by Cardio-Ankle Vascular Index in Patients with Idiopathic Pulmonary Hypertension.
    Vasc Health Risk Manag. 2021;17:77-93.
    PubMed    
    Abstract available

  124. NORDERFELDT J, Liliequist A, Frostell C, Adding C, et al
    Acute pulmonary hypertension and short-term outcomes in severe Covid-19 patients needing intensive care.
    Acta Anaesthesiol Scand. 2021 Mar 16. doi: 10.1111/aas.13819.
    PubMed    
    Abstract available

  125. KAGIOGLOU O, Mouratoglou SA, Giannakoulas G, Kapoukranidou D, et al
    Long-Term Effect of an Exercise Training Program on Physical Functioning and Quality of Life in Pulmonary Hypertension: A Randomized Controlled Trial.
    Biomed Res Int. 2021;2021:8870615.
    PubMed    
    Abstract available

  126. GUIHAIRE J, Deuse T, Wang D, Spin JM, et al
    Immunomodulation therapy using tolerogenic macrophages in a rodent model of pulmonary hypertension.
    Stem Cells Dev. 2021 Mar 17. doi: 10.1089/scd.2021.0007.
    PubMed    
    Abstract available

  127. DIGNAM JP, Scott TE, Kemp-Harper BK, Hobbs AJ, et al
    Animal models of pulmonary hypertension: Getting to the heart of the problem.
    Br J Pharmacol. 2021 Mar 16. doi: 10.1111/bph.15444.
    PubMed    
    Abstract available

  128. NICCUM M, Spyropoulos F, Levin JC, Petty CR, et al
    Lower oxygen saturation targets in preterm infants are not associated with increased rates of pulmonary hypertension.
    J Neonatal Perinatal Med. 2021 Mar 11. pii: NPM200637. doi: 10.3233/NPM-200637.
    PubMed    
    Abstract available

  129. SHMALTS AA, Gorbachevsky SV
    [Advantages and limitations of initial combination therapy in pulmonary arterial hypertension patients in Russia].
    Ter Arkh. 2020;92:80-85.
    PubMed    
    Abstract available

  130. ACOSTA MF, Muralidharan P, Grijalva CL, Abrahamson MD, et al
    Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in
    Ther Adv Respir Dis. 2021;15:1753466621998245.
    PubMed    
    Abstract available

  131. UYGUR B, Turkvatan Cansever A, Demir AR, Kahraman S, et al
    Detection of a rare cause of pulmonary hypertension by multimodality imaging: Left ventricular endomyocardial fibrosis.
    J Clin Ultrasound. 2021 Mar 14. doi: 10.1002/jcu.23003.
    PubMed    
    Abstract available

  132. ALZGHOUL BN, As Sayaideh M, Moreno BF, Singh SK, et al
    Pulmonary hypertension in eosinophilic versus noneosinophilic COPD.
    ERJ Open Res. 2021;7.
    PubMed    
    Abstract available

  133. BOBHATE P, Garg S, Sharma A, Roy D, et al
    Congenital extrahepatic portocaval malformation: Rare but potentially treatable cause of pulmonary hypertension.
    Indian Heart J. 2021;73:99-103.
    PubMed    
    Abstract available

  134. DE MARVAO A, Alexander D, Bucciarelli-Ducci C, Price S, et al
    Heart disease in women: a narrative review.
    Anaesthesia. 2021;76 Suppl 4:118-130.
    PubMed    
    Abstract available

  135. XU Z, Ruan J, Pan L, Chen C, et al
    Candidate Genes Identified in Systemic Sclerosis-Related Pulmonary Arterial Hypertension Were Associated with Immunity, Inflammation, and Cytokines.
    Cardiovasc Ther. 2021;2021:6651009.
    PubMed    
    Abstract available

  136. ZHANG T, Huang C, Luo H, Li J, et al
    Identification of key genes and immune profile in limited cutaneous systemic sclerosis-associated pulmonary arterial hypertension by bioinformatics analysis.
    Life Sci. 2021;271:119151.
    PubMed    
    Abstract available

  137. KUROSAWA R, Satoh K, Nakata T, Shindo T, et al
    Identification of Celastrol as a Novel Therapeutic Agent for Pulmonary Arterial Hypertension and Right Ventricular Failure Through Suppression of Bsg (Basigin)/CyPA (Cyclophilin A).
    Arterioscler Thromb Vasc Biol. 2021;41:1205-1217.
    PubMed    
    Abstract available

  138. PROENCA M, Braun F, Lemay M, Sola J, et al
    Non-invasive pulmonary artery pressure estimation by electrical impedance tomography in a controlled hypoxemia study in healthy subjects.
    Sci Rep. 2020;10:21462.
    PubMed    
    Abstract available

  139. VIRAY MC, Bonno EL, Gabrielle ND, Maron BA, et al
    Role of Pulmonary Artery Wedge Pressure Saturation During Right Heart Catheterization: A Prospective Study.
    Circ Heart Fail. 2020;13:e007981.
    PubMed    


  140. WANG W, Wang L, Feng P, Liu X, et al
    Real-world in-hospital outcomes and potential predictors of heart failure in primigravid women with heart disease in Southwestern China.
    BMC Pregnancy Childbirth. 2020;20:372.
    PubMed    
    Abstract available

  141. XANTHOULI P, Koegler M, Marra AM, Benjamin N, et al
    Risk stratification and prognostic factors in patients with pulmonary arterial hypertension and comorbidities a cross-sectional cohort study with survival follow-up.
    Respir Res. 2020;21:127.
    PubMed    
    Abstract available

  142. WEATHERALD J, Humbert M
    The 'great wait' for diagnosis in pulmonary arterial hypertension.
    Respirology. 2020;25:790-792.
    PubMed    


  143. AOZASA N, Hatano M, Saigusa R, Nakamura K, et al
    Clinical significance of endothelial vasodilatory function evaluated by EndoPAT in patients with systemic sclerosis.
    J Dermatol. 2020;47:609-614.
    PubMed    
    Abstract available

  144. MALENFANT S, Brassard P, Paquette M, Le Blanc O, et al
    Continuous reduction in cerebral oxygenation during endurance exercise in patients with pulmonary arterial hypertension.
    Physiol Rep. 2020;8:e14389.
    PubMed    
    Abstract available

  145. PRINS KW, Kalra R, Rose L, Assad TR, et al
    Hypochloremia Is a Noninvasive Predictor of Mortality in Pulmonary Arterial Hypertension.
    J Am Heart Assoc. 2020;9:e015221.
    PubMed    
    Abstract available

  146. JANDHYALA R
    Influence of Pharmaceutical Company Engagement Activities on the Decision to Prescribe: A Pilot Survey of UK Rare Disease Medicine Prescribers.
    Pharmaceut Med. 2020;34:127-134.
    PubMed    
    Abstract available

  147. PETETTA C, Tattoli L, Botta G, Di Vella G, et al
    Two autopsy cases of siblings with alveolar capillary dysplasia: clinical and post-mortem issues.
    Forensic Sci Med Pathol. 2020;16:180-183.
    PubMed    
    Abstract available

  148. AOYAMA BC, McGrath-Morrow SA, Collaco JM
    Characteristics of Children with Bronchopulmonary Dysplasia with Prolonged and/or Later-onset Pulmonary Hypertension.
    Ann Am Thorac Soc. 2021 Mar 26. doi: 10.1513/AnnalsATS.202012-1471.
    PubMed    


  149. IZZAT MB, Aljasem H, Izzat AW
    Pulmonary thromboendarterectomy for pulmonary hypertension linked to thalassemia.
    Clin Case Rep. 2021;9:1591-1593.
    PubMed    
    Abstract available

  150. SHANG X, Zhang C, Liu M, Lu R, et al
    Right Ventricular Contractility as a Potential Independent Evaluation Parameter in Pulmonary Hypertension.
    Int J Clin Pract. 2021 Mar 26:e14183. doi: 10.1111/ijcp.14183.
    PubMed    
    Abstract available

  151. FIGUEROA EG, Gonzalez-Candia A, Villanueva CA, Ebensperger G, et al
    Beneficial effects of melatonin on prostanoids pathways in pulmonary hypertensive neonates.
    Vascul Pharmacol. 2021 Mar 22:106853. doi: 10.1016/j.vph.2021.106853.
    PubMed    
    Abstract available

  152. MATHIAS M
    50 Years Ago in TheJournalofPediatrics: An Early Description of Persistent Pulmonary Hypertension of the Newborn.
    J Pediatr. 2021;231:230.
    PubMed    


  153. NAGEL C, Benjamin N, Egenlauf B, Eichstaedt CA, et al
    Effect of Supervised Training Therapy on Pulmonary Arterial Compliance and Stroke Volume in Severe Pulmonary Arterial Hypertension and Inoperable or Persistent Chronic Thromboembolic Pulmonary Hypertension.
    Respiration. 2021 Mar 25:1-10. doi: 10.1159/000512316.
    PubMed    
    Abstract available

  154. SCHIZAS N, Patris V, Giannaraki S, Ifanti G, et al
    Reversible Pulmonary Hypertension due to Combined Fistula between the Left Anterior Descending Artery (LAD) and Pulmonary Artery and Severe Stenosis of the LAD.
    Case Rep Cardiol. 2021;2021:6629684.
    PubMed    
    Abstract available

  155. NIZNANSKY M, Kavan J, Zemankova P, Prskavec T, et al
    Computed tomography angiographic parameters of pulmonary artery as prognostic factors of residual pulmonary hypertension after pulmonary endarterectomy.
    J Int Med Res. 2021;49:3000605211002024.
    PubMed    
    Abstract available

  156. YOUNG A, Moles VM, Jaafar S, Visovatti S, et al
    Performance of the DETECT Algorithm for Pulmonary Hypertension Screening in a Systemic Sclerosis Cohort.
    Arthritis Rheumatol. 2021 Mar 24. doi: 10.1002/art.41732.
    PubMed    
    Abstract available

  157. SAETUNG M, Kritsaneepaiboon S, Jarutach J
    Main pulmonary artery-to-descending aorta ratio in computed tomography: cut-off value to diagnose pulmonary hypertension in children.
    Pol J Radiol. 2021;86:e87-e92.
    PubMed    
    Abstract available

  158. XUE L, Yang Y, Sun B, Liu B, et al
    Mildly Elevated Pulmonary Arterial Pressure Is Associated With a High Risk of Progression to Pulmonary Hypertension and Increased Mortality: A Systematic Review and Meta-Analysis.
    J Am Heart Assoc. 2021 Mar 23:e018374. doi: 10.1161/JAHA.120.018374.
    PubMed    
    Abstract available

  159. ATASAYAN V, CanbeylI F, TunaoGlu FS, OGuz AD, et al
    Prognostic value of oxygen saturation and heart rate during six-minute walk test in pediatric pulmonary hypertension.
    Turk J Med Sci. 2021 Mar 23. doi: 10.3906/sag-2004.
    PubMed    
    Abstract available

  160. GHATTAS C, Channick RN, Wright CD, Vlahakes GJ, et al
    Vascular Endobronchial Ultrasound in a Patient With Chronic Thromboembolic Pulmonary Hypertension.
    J Bronchology Interv Pulmonol. 2021;28:e23-e26.
    PubMed    


  161. VAIDY A, Forfia P, Mazurek J, Vaidya A, et al
    Improvement after bariatric surgery in chronic thromboembolic pulmonary hypertension: a novel treatment target.
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  162. BRUNNER NW, Legkaia L, Al-Ahmadi F, Lee L, et al
    Does community size or commute time affect severity of illness at diagnosis or quality of care in a centralized care model of pulmonary hypertension?
    Int J Cardiol. 2021 Mar 18. pii: S0167-5273(21)00537.
    PubMed    
    Abstract available

  163. SHI Y, Jiang R, Qin X, Gao A, et al
    Up-regulation of nPKC contributes to proliferation of mice pulmonary artery smooth muscle cells in hypoxia-induced pulmonary hypertension.
    Eur J Pharmacol. 2021 Mar 18:174046. doi: 10.1016/j.ejphar.2021.174046.
    PubMed    
    Abstract available

  164. SHIMOKAWAHARA H, Nagayoshi S, Ogawa A, Matsubara H, et al
    Continual Improvement in Pressure Gradient at the Lesion after Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    Can J Cardiol. 2021 Mar 17. pii: S0828-282X(21)00158.
    PubMed    
    Abstract available

  165. MONDEJAR-PARRENO G, Cogolludo A, Perez-Vizcaino F
    Potassium (K(+)) channels in the pulmonary vasculature: Implications in pulmonary hypertension Physiological, pathophysiological and pharmacological regulation.
    Pharmacol Ther. 2021 Mar 17:107835. doi: 10.1016/j.pharmthera.2021.107835.
    PubMed    
    Abstract available

  166. RYANTO GRT, Ikeda K, Miyagawa K, Tu L, et al
    An endothelial activin A-bone morphogenetic protein receptor type 2 link is overdriven in pulmonary hypertension.
    Nat Commun. 2021;12:1720.
    PubMed    
    Abstract available

  167. MENDES SL, Moreira N, Batista M, Ferreira AR, et al
    Long-Term Clinical and Hemodynamic Outcomes after Heart Transplantation in Patients Pre-Treated with Sildenafil.
    Arq Bras Cardiol. 2021;116:219-226.
    PubMed    
    Abstract available

  168. SUN XQ, Peters EL, Schalij I, Axelsen JB, et al
    Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2021;64:331-343.
    PubMed    
    Abstract available

  169. CARBONE A, Linkova N, Polyakova V, Mironova E, et al
    Melatonin and Sirtuins in Buccal Epithelium: Potential Biomarkers of Aging and Age-Related Pathologies.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  170. LIU K, Zhang C, Chen B, Li M, et al
    Association between right atrial area measured by echocardiography and prognosis among pulmonary arterial hypertension: a systematic review and meta-analysis.
    BMJ Open. 2020;10:e031316.
    PubMed    
    Abstract available

  171. IMAMURA T, Narang N
    Implication of Hemodynamic Assessment during Durable Left Ventricular Assist Device Support.
    Medicina (Kaunas). 2020;56.
    PubMed    
    Abstract available

  172. SWIGRIS JJ
    The 4-min mile and supplemental oxygen in IPF.
    Respirology. 2020;25:1114-1115.
    PubMed    


  173. GOMEZ-PUERTO MC, Sun XQ, Schalij I, Orriols M, et al
    MnTBAP Reverses Pulmonary Vascular Remodeling and Improves Cardiac Function in Experimentally Induced Pulmonary Arterial Hypertension.
    Int J Mol Sci. 2020;21.
    PubMed    
    Abstract available

  174. MARTIROSOV AL, Smith ZR, Hencken L, MacDonald NC, et al
    Improving transitions of care for critically ill adult patients on pulmonary arterial hypertension medications.
    Am J Health Syst Pharm. 2020;77:958-965.
    PubMed    
    Abstract available

  175. QIU J, Guo Y, Xu X, Yue H, et al
    Ginkgo leaf extract and dipyridamole injection for chronic cor pulmonale: a PRISMA-compliant meta-analysis of randomized controlled trials.
    Biosci Rep. 2020;40.
    PubMed    
    Abstract available

  176. ZOU H, Leng S, Xi C, Zhao X, et al
    Three-dimensional biventricular strains in pulmonary arterial hypertension patients using hyperelastic warping.
    Comput Methods Programs Biomed. 2020;189:105345.
    PubMed    
    Abstract available

  177. LACHANT DJ, Light AN, Mackin ML, Schwartz RG, et al
    Heart Rate Expenditure Correlates with Right Ventricular Function.
    Ann Am Thorac Soc. 2020;17:372-375.
    PubMed    


  178. BECKER S, Spiesshoefer J, Brix T, Tuleta I, et al
    Validity of transit time-based blood pressure measurements in patients with and without heart failure or pulmonary arterial hypertension across different breathing maneuvers.
    Sleep Breath. 2020;24:221-230.
    PubMed    
    Abstract available

  179. OJHA V, Chandrashekhara S, Vadher A, Malhi AS, et al
    A rare association of mitral atresia and double outlet right ventricle (MA-DORV) with unicuspid pulmonary valve.
    Acta Cardiol. 2020;75:267-268.
    PubMed    


  180. YOSHIHARA S, Suzuki S, Matsunaga M, Ohnishi I, et al
    Right ventricular fibrosis in idiopathic pulmonary arterial hypertension.
    Acta Cardiol. 2020;75:263-264.
    PubMed    


  181. RICHTER MJ, Hsu S, Yogeswaran A, Husain-Syed F, et al
    Right ventricular pressure-volume loop shape and systolic pressure change in pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021 Mar 3. doi: 10.1152/ajplung.00583.2020.
    PubMed    
    Abstract available

  182. HADZIC S, Wu CY, Gredic M, Kojonazarov B, et al
    The effect of long-term doxycycline treatment in a mouse model of cigarette smoke-induced emphysema and pulmonary hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2021 Mar 24. doi: 10.1152/ajplung.00048.2021
    PubMed    
    Abstract available

  183. BONNET S, Gomez D
    RNA Methylation: A New Regulator of Vascular Remodeling in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2021 Feb 26. doi: 10.1164/rccm.202011-4185.
    PubMed    


  184. SOCKRIDER M
    What Is Pulmonary Hypertension?
    Am J Respir Crit Care Med. 2021;203:P12-P13.
    PubMed    


  185. KARNES JH, Schwantes-An TH, Kittles R, Desai AA, et al
    Reply to Non and Chang: Challenging the Role of Genetic Ancestry in Explaining Racial/Ethnic Health Disparities.
    Am J Respir Crit Care Med. 2021;203:398-399.
    PubMed    


  186. NON AL, Chang SY
    Challenging the Role of Genetic Ancestry in Explaining Racial/Ethnic Health Disparities.
    Am J Respir Crit Care Med. 2021;203:397-398.
    PubMed    


  187. BADAGLIACCA R, D'Alto M, Ghio S, Vizza CD, et al
    Reply to Weatherald et al.: Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Piece de Resistance?
    Am J Respir Crit Care Med. 2021;203:525-526.
    PubMed    


  188. WEATHERALD J, Boucly A, Savale L, Jais X, et al
    Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Piece de Resistance?
    Am J Respir Crit Care Med. 2021;203:524-525.
    PubMed    


  189. HIRAIDE T, Teratani T, Uemura S, Yoshimatsu Y, et al
    Pulmonary Arterial Hypertension Caused by AhR Signal Activation Protecting against Colitis.
    Am J Respir Crit Care Med. 2021;203:385-388.
    PubMed    


  190. SCHOENBERG NC, Farber HW
    When "AMBITION" Isn't Good Enough: Risk Status and Dual Oral Therapy in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:410-411.
    PubMed    


  191. KHURAL JS, Houston BA, Leary PJ, Mathai SC, et al
    Right Atrial Pacing to Improve Acute Hemodynamics in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:508-511.
    PubMed    


  192. BADAGLIACCA R, D'Alto M, Ghio S, Argiento P, et al
    Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension.
    Am J Respir Crit Care Med. 2021;203:484-492.
    PubMed    
    Abstract available

  193. SOCKRIDER M, Roessel L, Fagan KA, Gillespie M, et al
    Diagnosis and Treatment of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2021;203:P14-P15.
    PubMed    


  194. WANG J, Yang K, Yuan JX
    NEDD9, a Hypoxia-upregulated Mediator for Pathogenic Platelet-endothelial Cell Interaction in Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2021 Mar 26. doi: 10.1164/rccm.202101-0007.
    PubMed    


  195. ZHU L, Liu F, Hao Q, Feng T, et al
    Dietary Geranylgeranyl Pyrophosphate Counteracts the Benefits of Statin Therapy in Experimental Pulmonary Hypertension.
    Circulation. 2021 Mar 4. doi: 10.1161/CIRCULATIONAHA.120.046542.
    PubMed    
    Abstract available

  196. CONDLIFFE R, Kiely DG, Lewis RA
    Mild parenchymal lung disease is still lung disease.
    Eur Respir J. 2020;56.
    PubMed    


  197. GODINAS L, Harari S, Barbera JA, Montani D, et al
    Mild parenchymal lung disease is still lung disease.
    Eur Respir J. 2020;56.
    PubMed    


  198. RHODES CJ
    The cancer hypothesis of pulmonary arterial hypertension: are polyamines the new Warburg?
    Eur Respir J. 2020;56.
    PubMed    


  199. CHAWLA D
    Vasopressin in Persistent Pulmonary Hypertension of Newborn.
    Indian J Pediatr. 2021 Mar 26. pii: 10.1007/s12098-021-03732.
    PubMed    


  200. OPOTOWSKY AR, Dimopoulos K, Buber J
    Implications of Elevated Pulmonary Artery Pressure for Transcatheter Mitral Repair: Time for Comprehensive Hemodynamic Investigation.
    J Am Coll Cardiol. 2020;76:2607-2610.
    PubMed    


  201. LATUS H, Apitz C
    Exercise-Induced Pulmonary Hypertension: The Final Answer to Characterize Pulmonary Vascular Disease in Fontan Patients?
    J Am Coll Cardiol. 2021;77:1594-1595.
    PubMed    


  202. RANGANATH NK, Smith DE, Kon ZN
    Awareness of bias in lung transplant registry analyses.
    J Heart Lung Transplant. 2020;39:850-851.
    PubMed    


  203. WESLEY MILKS M, Sahay S, Benza RL, Farber HW, et al
    Risk assessment in patients with pulmonary arterial hypertension in the era of COVID 19 pandemic and the telehealth revolution: State of the art review.
    J Heart Lung Transplant. 2021;40:172-182.
    PubMed    
    Abstract available

  204. BRAAMS NJ, van Leeuwen JW, Vonk Noordegraaf A, Nossent EJ, et al
    Right ventricular adaptation to pressure-overload: Differences between chronic thromboembolic pulmonary hypertension and idiopathic pulmonary arterial hypertension.
    J Heart Lung Transplant. 2021 Feb 28. pii: S1053-2498(21)02216.
    PubMed    
    Abstract available

  205. NATHAN SD, Cottin V, Behr J, Hoeper MM, et al
    Impact of lung morphology on clinical outcomes with riociguat in patients with pulmonary hypertension and idiopathic interstitial pneumonia: A post hoc subgroup analysis of the RISE-IIP study.
    J Heart Lung Transplant. 2021 Feb 19. pii: S1053-2498(21)02178.
    PubMed    
    Abstract available

  206. SEABROOK RB, Grover TR, Rintoul N, Weems M, et al
    Treatment of pulmonary hypertension during initial hospitalization in a multicenter cohort of infants with congenital diaphragmatic hernia (CDH).
    J Perinatol. 2021 Mar 1. pii: 10.1038/s41372-021-00923.
    PubMed    
    Abstract available

  207. DASGUPTA S, Richardson JC, Aly AM, Jain SK, et al
    Role of functional echocardiographic parameters in the diagnosis of bronchopulmonary dysplasia-associated pulmonary hypertension.
    J Perinatol. 2021 Mar 8. pii: 10.1038/s41372-021-01009.
    PubMed    
    Abstract available

  208. THANGAPPAN K, Morales DLS
    Commentary: To transplant or not to transplant: Potts shunt as an alternative to pediatric lung transplantation.
    J Thorac Cardiovasc Surg. 2020 Nov 24. pii: S0022-5223(20)33124.
    PubMed    


  209. ROSENZWEIG EB, Bacha E
    Commentary: Will the reversed Potts shunt replace lung transplantation for children with end-stage pulmonary arterial hypertension?
    J Thorac Cardiovasc Surg. 2020 Nov 19. pii: S0022-5223(20)33071.
    PubMed    


  210. MILLER JR, Eghtesady P
    Commentary: Potts shunt for pulmonary hypertension: Are we making progress?
    J Thorac Cardiovasc Surg. 2021;161:1449-1450.
    PubMed    


  211. SAID SM
    Commentary: Right ventricular unloading with valved conduit for end-stage pulmonary arterial hypertension: When Eisenmenger is the last hurrah.
    J Thorac Cardiovasc Surg. 2021;161:1447-1448.
    PubMed    


  212. TAN C, Huddleston CB
    Commentary: Proceed with caution.
    J Thorac Cardiovasc Surg. 2021;161:1451-1452.
    PubMed    


  213. BOON GJAM, Ende-Verhaar YM, Bavalia R, El Bouazzaoui LH, et al
    Non-invasive early exclusion of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: the InShape II study.
    Thorax. 2021 Mar 23. pii: thoraxjnl-2020-216324.
    PubMed    
    Abstract available

  214. SUZUKI Y, Oishi H, Matsuda Y, Noda M, et al
    Pneumonia With Scedosporium apiospermum and Lomentospora prolificans in a Patient After Bilateral Lung Transplantation for Pulmonary Hypertension: A Case Report.
    Transplant Proc. 2021 Mar 8. pii: S0041-1345(21)00114.
    PubMed    
    Abstract available

  215. RAJARATNAM A, Rehman S, Sharma P, Singh VK, et al
    Right ventricular load and contractility in HIV-associated pulmonary hypertension.
    PLoS One. 2021;16:e0243274.
    PubMed    
    Abstract available

  216. IBE T, Wada H, Sakakura K, Ugata Y, et al
    Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
    PLoS One. 2021;16:e0247987.
    PubMed    
    Abstract available

  217. HONIGBERG MC, Patel AP, Lahm T, Wood MJ, et al
    Association of premature menopause with incident pulmonary hypertension: A cohort study.
    PLoS One. 2021;16:e0247398.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;